Innoviva, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Innoviva, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $69.52M | Feb 23, 2018 |
| FY2017 | Sep 30, 2017 | $48.64M | Feb 23, 2018 |
| FY2017 | Jun 30, 2017 | $58.56M | Feb 23, 2018 |
| FY2017 | Mar 31, 2017 | $40.49M | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $43.61M | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | $33.31M | Feb 23, 2018 |
| FY2017 | Jun 30, 2016 | $32.47M | Feb 23, 2018 |
| FY2017 | Mar 31, 2016 | $24.18M | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $22.84M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $13.56M | Feb 28, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $411.33M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $358.71M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $310.46M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $331.34M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $391.87M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $336.79M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $75.97M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $65.76M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $64.11M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $55.18M | Feb 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $163.75M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $166.87M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $113.89M | Feb 25, 2026 |
| FY2021 | Dec 31, 2021 | $375.10M | Mar 17, 2022 |
| FY2021 | Dec 31, 2020 | $321.12M | Mar 17, 2022 |
| FY2019 | Dec 31, 2019 | $73.64M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $60.79M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $59.76M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $52.17M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $77.22M | Feb 19, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.30B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.24B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.23B | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $926.40M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $999.57M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $724.83M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $548.19M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $367.34M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $379.00M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $691.16M | Feb 25, 2026 |
| FY2022 | Dec 31, 2022 | $565.79M | Feb 28, 2023 |
| FY2022 | Dec 31, 2021 | $414.74M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $539.91M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $313.50M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $153.58M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($242.86M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($352.99M) | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | ($342.65M) | Feb 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 19, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 19, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $550.94M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $304.96M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $193.51M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $291.05M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $201.53M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $246.49M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $278.10M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $62.42M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $73.34M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $118.02M | Feb 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $748.27M | Feb 24, 2016 |
| FY2015 | Dec 31, 2014 | $725.64M | Feb 24, 2016 |
| FY2014 | Dec 31, 2013 | $287.50M | Feb 27, 2015 |